15.35
+1.35(+9.64%)
Currency In USD
| Previous Close | 14 |
| Open | 14 |
| Day High | 15.49 |
| Day Low | 13.6 |
| 52-Week High | 16 |
| 52-Week Low | 3.39 |
| Volume | 364,321 |
| Average Volume | 325,804 |
| Market Cap | 201.89M |
| PE | 2.35 |
| EPS | 6.54 |
| Moving Average 50 Days | 11.27 |
| Moving Average 200 Days | 7.41 |
| Change | 1.35 |
If you invested $1000 in Avalo Therapeutics, Inc. (AVTX) 10 years ago, it would be worth $0.87 as of October 20, 2025 at a share price of $15.35. Whereas If you bought $1000 worth of Avalo Therapeutics, Inc. (AVTX) shares 5 years ago, it would be worth $2.25 as of October 20, 2025 at a share price of $15.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
GlobeNewswire Inc.
Oct 01, 2025 11:00 AM GMT
WAYNE, Pa., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the expans
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
GlobeNewswire Inc.
Sep 22, 2025 11:00 AM GMT
WAYNE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the appoi
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
GlobeNewswire Inc.
Jun 18, 2025 11:00 AM GMT
WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the appointment of Rita Jain, M.D. to its Board of Direc